肥厚性心肌病
MYH7
室间隔
内科学
心脏病学
医学
心肌病
遗传学
生物
心力衰竭
基因
基因亚型
心室
作者
Walter Serra,Giulia Vitetta,Vera Uliana,Federico Barocelli,Valeria Barili,Isabella Allegri,Diego Ardissino,Francesca Gualandi,Antonio Percesepe
出处
期刊:Heliyon
[Elsevier]
日期:2022-12-01
卷期号:8 (12): e12373-e12373
被引量:3
标识
DOI:10.1016/j.heliyon.2022.e12373
摘要
Hypertrophic cardiomyopathy is an autosomal dominant disease. The main feature of this disorder is its occurrence in patients who present a left ventricular hypertrophy, unexplained by the loading conditions, usually asymmetric with greatest involvement most commonly of the interventricular septum.Case presentation During a sports medicine control, a ultrasound scan in a 17 years old patient has shown a concentric left ventricular parietal hypertrophy associated with a 23 mm mid- basal interventricular septum thickness. After genetic counselling, a positive family history for hypertrophic cardiac disease and parents' consanguineity was found. The genetic basis of the hypertrophic cardiomyopathy was investigated through a dedicated gene panel. The genetic test has revealed the presence of the variant c.3424G>A (p.Glu1142Lys) in the MYH7 gene in a homozygous state. Genotyping of the parents and of the two brothers revealed the presence of the MYH7 variant in heterozygosity in both parents and in the younger brother. In all of them, variable signs of hypertrophic cardiomyopathy were found.Our findings report the presence of a homozygous variant in a sarcomeric gene (MYH7) which gave rise to early HCM, whereas the variant in a heterozygous state was associated to much milder cardiac phenotypes in the affected relatives. The onset and the progression of the hypertrophic cardiomyopathy in the reported family is to be referred to the presence of the variant in hetero- or homo-zygosity in a gene dosage manner.
科研通智能强力驱动
Strongly Powered by AbleSci AI